5.240USD+1.35%Mkt Cap: 815.16M USDP/E: —Last update: 2026-05-22
Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access i…
Industry Peers
Health Information Servicesloading…
Indicators:|
Key Statistics
Company
Market Cap815.16M USD
Enterprise Value959.42M USD
Revenue (TTM)419.75M USD
Gross Profit257.71M USD
Net Income (TTM)-1.59M USD
Revenue/Share2.630 USD
Last Price5.240 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees1.5K
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)12.51
PEG—
EV/EBITDA10.20
EV/Revenue2.29
P/S1.92
P/B0.78
EPS (TTM)-0.11
EPS (Forward)0.41
52W Range
4.4508% of range13.88
52W High13.88 USD
52W Low4.450 USD
Profitability
Gross Margin61.53%
Oper. Margin3.80%
EBITDA Margin22.40%
Profit Margin-0.38%
ROE-0.15%
ROA-0.10%
Growth
Revenue Growth0.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF96.33M USD
CapEx (TTM)26.56M USD
FCF Margin27.77%
FCF Yield14.30%
Net Debt155.15M USD
Net Debt/EBITDA1.65
Balance Sheet
Debt/Equity0.29
Current Ratio1.88
Quick Ratio1.78
Book Value/Sh6.633 USD
Cash/Share0.9610 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.2 (Buy)
Target (Mean)7.618 USD
Target Range6.000 USD – 10.00 USD
# Analysts11
Ownership
Shares Out.155.56M
Float107.30M
Insiders2.56%
Institutions113.31%
Short Interest
Short Ratio6.2d
Short % Float24.57%
Short % Out.15.73%
Shares Short24.12M
Short (prev mo.)22.29M
Technical
SMA 505.837 (-10.2%)
SMA 2008.807 (-40.5%)
Beta1.53
S&P 52W Chg28.31%
Avg Vol (30d)3.37M
Avg Vol (10d)4.79M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—